Education

Medical School
Cerrahpasa Medical School
Internship
Maimonides Medical Center (2016), Internal Medicine
Residency
Sinai Hospital of Baltimore (2019), Internal Medicine
Fellowship
George Washington University (2021), Hematology Oncology
Fellowship
MedStar Georgetown University Hospital (2022), Hematology Oncology

Publications

Featured Publications LegendFeatured Publications

A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.
Yilmaz E, Chhina A, Nava VE, Aggarwal A, Curr Oncol 2021 12 28 6 5148-5154
Survival after autologous versus allogeneic transplantation in patients with relapsed and refractory Hodgkin lymphoma.
Fakhri B, Yilmaz E, Gao F, Ambinder RF, Jones R, Bartlett NL, Cashen A, Wagner-Johnston N, Leuk Lymphoma 2021 10 62 10 2408-2415
Phase 2 Study of Nivolumab in Epstein-BarrVirus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas.
Yilmaz E, Lakhotia R, Pittaluga S, Muppidi J, Phelan JD, Evans S, Pradhan A, Hillsman A, SteinbergSM, Jaffe ES, Wilson WH, Roschewski M, Melani C Blood 2021
Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.
Deng J, Isik E, Fernandes SM, Brown JR, Letai A, Davids MS, Leukemia 2017 10 31 10 2075-2084
Direct and immune-mediated cytotoxicity of interleukin-21 contributes to anti-tumor effects in mantle cell lymphoma.
Bhatt S, Matthews J, Parvin S, Sarosiek KA, Zhao D, Jiang X, Isik E, Letai A, Lossos IS Blood 2015 Jul